Tumour necrosis factor and cachexia: a current perspective
Authors:
- E.M. CopelandECE.M. Copeland
- L.L. MoldawerLML.L. Moldawer
- 1 October 1994
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 3 (5) , 255-262
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon.Journal of Experimental Medicine, 1994
- Nitric Oxide-Releasing Agents Enhance Cytokine-Induced Tumor Necrosis Factor Synthesis in Human Mononuclear CellsBiochemical and Biophysical Research Communications, 1993
- Effect of recombinant human cytokines on porcine neutrophil functionVeterinary Immunology and Immunopathology, 1993
- Interleukin-1 TNFα and Their Naturally Occurring Antagonists in SepsisBlood Purification, 1993
- Cytokines and Their Role in the Pathophysiology of Cancer CachexiaJournal of Parenteral and Enteral Nutrition, 1992
- Molecular cloning and expression of a receptor for human tumor necrosis factorCell, 1990
- Monocytic production and plasma bioactivities of interleukin‐1 and tumour necrosis factor in human cancerEuropean Journal of Clinical Investigation, 1988
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: Role of defective triglyceride removalMolecular and Biochemical Parasitology, 1980